Correlation Between Puma Biotechnology and Greenwich Lifesciences
Can any of the company-specific risk be diversified away by investing in both Puma Biotechnology and Greenwich Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puma Biotechnology and Greenwich Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Puma Biotechnology and Greenwich Lifesciences, you can compare the effects of market volatilities on Puma Biotechnology and Greenwich Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puma Biotechnology with a short position of Greenwich Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puma Biotechnology and Greenwich Lifesciences.
Diversification Opportunities for Puma Biotechnology and Greenwich Lifesciences
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between Puma and Greenwich is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and Greenwich Lifesciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Greenwich Lifesciences and Puma Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puma Biotechnology are associated (or correlated) with Greenwich Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Greenwich Lifesciences has no effect on the direction of Puma Biotechnology i.e., Puma Biotechnology and Greenwich Lifesciences go up and down completely randomly.
Pair Corralation between Puma Biotechnology and Greenwich Lifesciences
Given the investment horizon of 90 days Puma Biotechnology is expected to generate 1.46 times more return on investment than Greenwich Lifesciences. However, Puma Biotechnology is 1.46 times more volatile than Greenwich Lifesciences. It trades about 0.07 of its potential returns per unit of risk. Greenwich Lifesciences is currently generating about -0.02 per unit of risk. If you would invest 252.00 in Puma Biotechnology on September 16, 2024 and sell it today you would earn a total of 36.00 from holding Puma Biotechnology or generate 14.29% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Puma Biotechnology vs. Greenwich Lifesciences
Performance |
Timeline |
Puma Biotechnology |
Greenwich Lifesciences |
Puma Biotechnology and Greenwich Lifesciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Puma Biotechnology and Greenwich Lifesciences
The main advantage of trading using opposite Puma Biotechnology and Greenwich Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puma Biotechnology position performs unexpectedly, Greenwich Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Greenwich Lifesciences will offset losses from the drop in Greenwich Lifesciences' long position.Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
Greenwich Lifesciences vs. Puma Biotechnology | Greenwich Lifesciences vs. Iovance Biotherapeutics | Greenwich Lifesciences vs. Zentalis Pharmaceuticals Llc | Greenwich Lifesciences vs. Syndax Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |